North America Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diag...

North America organ transplant diagnostics market is projected to grow by 8.1% annually in the forecast period and reach $2,227.2 million by 2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of te...

44742 | Healthcare and Social Assistance

Global Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics...

Global organ transplant diagnostics market will reach $6,072.1 million by 2031, growing by 8.8% annually over 2021-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced dev...

44742 | Healthcare and Social Assistance

Asia Pacific Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointment...

Asia Pacific ophthalmic drug delivery system market will grow by 8.9% annually with a total addressable market cap of $56,139.1 million over 2022-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures th...

44742 | Healthcare and Social Assistance

Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Sus...

Europe ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive...

44742 | Healthcare and Social Assistance

North America Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointmen...

North America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures tha...

44742 | Healthcare and Social Assistance

Global Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Sus...

Global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post ...

44742 | Healthcare and Social Assistance

Asia Pacific Lipid Nutrition (Nutritional Lipids) Market 2021-2031 by Product (Omega-3, Omega-6, MCT, Phytosterols), Source (Plant, Animal), Form (Liquid, Powder), Application (Supplements & Nutraceut...

Asia Pacific lipid nutrition market will grow by 8.9% annually with a total addressable market cap of $42,032.4 million over 2022-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household ...

44742 | Healthcare and Social Assistance

Europe Lipid Nutrition (Nutritional Lipids) Market 2021-2031 by Product (Omega-3, Omega-6, MCT, Phytosterols), Source (Plant, Animal), Form (Liquid, Powder), Application (Supplements & Nutraceuticals,...

Europe lipid nutrition market was valued at $2,073.7 million in 2021 and will grow by 6.1% annually over 2021-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surg...

44742 | Healthcare and Social Assistance

North America Lipid Nutrition (Nutritional Lipids) Market 2021-2031 by Product (Omega-3, Omega-6, MCT, Phytosterols), Source (Plant, Animal), Form (Liquid, Powder), Application (Supplements & Nutraceu...

North America lipid nutrition market is projected to grow by 7.1% annually in the forecast period and reach $5,368.8 million by 2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household in...

44742 | Healthcare and Social Assistance

Global Lipid Nutrition (Nutritional Lipids) Market 2021-2031 by Product (Omega-3, Omega-6, MCT, Phytosterols), Source (Plant, Animal), Form (Liquid, Powder), Application (Supplements & Nutraceuticals,...

Global lipid nutrition market will reach $ 17,516.6 million by 2031, growing by 7.6% annually over 2021-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surged nee...

44742 | Healthcare and Social Assistance

First
Previous
1
2
3
4
5
6
7
8
9
10
Next

North America organ transplant diagnostics market is projected to grow by 8.1% annually in the forecast period and reach $2,227.2 million by 2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics. Highlighted with 31 tables and 58 figures, this 123-page report “North America Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Country. Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Test Kits & Consumables o Kits & Assays o Consumables • Software & Services Based on Transplant, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solid Organ Transplant o Kidney o Liver o Heart o Lung o Pancreas o Kidney-Pancreas o Other Solid Organ Transplants • Stem Cell Transplant • Soft Tissue Transplant By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostics o Donor Testing o Recipient Testing • Translational Research By Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Molecular Technologies o PCR o Sequencing o Other Molecular Technologies • Serology • Flow Cytometry • Other Technologies By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Transplant Centers • Reference Laboratories • Academic and Research Institutions • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Transplant and Technology over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Inc. ARUP Laboratories BAG Health Care GmbH Becton Dickinson and Company bioMérieux S.A. Bio-Rad Laboratories, Inc. CareDx, Inc. Eurofins Scientific F. Hoffmann-La Roche Ltd. Illumina, Inc. Immucor, Inc. Laboratory Corporation of America Holdings Novacyt Group Omixon Ltd. OPKO Health QIAGEN N.V. Quest Diagnostics Incorporated Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Global organ transplant diagnostics market will reach $6,072.1 million by 2031, growing by 8.8% annually over 2021-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics. Highlighted with 91 tables and 94 figures, this 185-page report “Global Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Region. Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Test Kits & Consumables o Kits & Assays o Consumables • Software & Services Based on Transplant, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solid Organ Transplant o Kidney o Liver o Heart o Lung o Pancreas o Kidney-Pancreas o Other Solid Organ Transplants • Stem Cell Transplant • Soft Tissue Transplant By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostics o Donor Testing o Recipient Testing • Translational Research By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Molecular Technologies o PCR o Sequencing o Other Molecular Technologies • Serology • Flow Cytometry • Other Technologies By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Transplant Centers • Reference Laboratories • Academic and Research Institutions • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE，Saudi Arabia， South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market Offering, Transplant and Technology over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Inc. ARUP Laboratories BAG Health Care GmbH Becton Dickinson and Company bioMérieux S.A. Bio-Rad Laboratories, Inc. CareDx, Inc. Eurofins Scientific F. Hoffmann-La Roche Ltd. Illumina, Inc. Immucor, Inc. Laboratory Corporation of America Holdings Novacyt Group Omixon Ltd. OPKO Health QIAGEN N.V. Quest Diagnostics Incorporated Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Asia Pacific ophthalmic drug delivery system market will grow by 8.9% annually with a total addressable market cap of $56,139.1 million over 2022-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 27 tables and 56 figures, this 127-page report “Asia Pacific Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pre-filled Syringes • Multidose Eyedroppers • Squeeze Dispensers • Mist Sprayers • Contact Lenses • Ocular Inserts • Intraocular Implants • Punctal Plugs • Other Products Based on Dosage Form, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solutions • Gels • Ointments • Suspensions • Emulsions • Liposomes & Nanoparticles By Disease, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Glaucoma • Diabetic Retinopathy • Cataract • Dry Eye Syndrome • Macular Degeneration • Diabetic Macular Edema • Refractive Issues • Other Diseases By Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Homecare Settings • Ambulatory Surgical Centers (ASCs) • Other Settings Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Dosage Form, and Setting over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Aero Pump GmbH Allergan plc. AptarGroup, Inc. Becton, Dickinson and Company Biocorp Clearside Biomedical, Inc. EyePoint Pharmaceuticals, Inc. Gaplast GmbH Gerresheimer AG Jotteq Inc. Kedalion Therapeutics, Inc. Mati Therapeutics, Inc. Nemera Nipro Corporation Ocular Therapeutix, Inc. Ocumedic, Inc. Owen Mumford Re-Vana Therapeutics Silgan Holdings Inc. Terumo Corporation Valeant Pharmaceuticals International Inc. (Bausch Health Company) West Pharmaceutical Services, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Europe ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 30 tables and 57 figures, this 127-page report “Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pre-filled Syringes • Multidose Eyedroppers • Squeeze Dispensers • Mist Sprayers • Contact Lenses • Ocular Inserts • Intraocular Implants • Punctal Plugs • Other Products Based on Dosage Form, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solutions • Gels • Ointments • Suspensions • Emulsions • Liposomes & Nanoparticles By Disease, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Glaucoma • Diabetic Retinopathy • Cataract • Dry Eye Syndrome • Macular Degeneration • Diabetic Macular Edema • Refractive Issues • Other Diseases By Setting, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Homecare Settings • Ambulatory Surgical Centers (ASCs) • Other Settings Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Dosage Form, and Setting over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Aero Pump GmbH Allergan plc. AptarGroup, Inc. Becton, Dickinson and Company Biocorp Clearside Biomedical, Inc. EyePoint Pharmaceuticals, Inc. Gaplast GmbH Gerresheimer AG Jotteq Inc. Kedalion Therapeutics, Inc. Mati Therapeutics, Inc. Nemera Nipro Corporation Ocular Therapeutix, Inc. Ocumedic, Inc. Owen Mumford Re-Vana Therapeutics Silgan Holdings Inc. Terumo Corporation Valeant Pharmaceuticals International Inc. (Bausch Health Company) West Pharmaceutical Services, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

North America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 20 tables and 53 figures, this 116-page report “North America Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Country. Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pre-filled Syringes • Multidose Eyedroppers • Squeeze Dispensers • Mist Sprayers • Contact Lenses • Ocular Inserts • Intraocular Implants • Punctal Plugs • Other Products Based on Dosage Form, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solutions • Gels • Ointments • Suspensions • Emulsions • Liposomes & Nanoparticles By Disease, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Glaucoma • Diabetic Retinopathy • Cataract • Dry Eye Syndrome • Macular Degeneration • Diabetic Macular Edema • Refractive Issues • Other Diseases By Setting, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Homecare Settings • Ambulatory Surgical Centers (ASCs) • Other Settings Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Dosage Form, and Setting over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Aero Pump GmbH Allergan plc. AptarGroup, Inc. Becton, Dickinson and Company Biocorp Clearside Biomedical, Inc. EyePoint Pharmaceuticals, Inc. Gaplast GmbH Gerresheimer AG Jotteq Inc. Kedalion Therapeutics, Inc. Mati Therapeutics, Inc. Nemera Nipro Corporation Ocular Therapeutix, Inc. Ocumedic, Inc. Owen Mumford Re-Vana Therapeutics Silgan Holdings Inc. Terumo Corporation Valeant Pharmaceuticals International Inc. (Bausch Health Company) West Pharmaceutical Services, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 80 tables and 89 figures, this 196-page report “Global Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pre-filled Syringes • Multidose Eyedroppers • Squeeze Dispensers • Mist Sprayers • Contact Lenses • Ocular Inserts • Intraocular Implants • Punctal Plugs • Other Products Based on Dosage Form, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solutions • Gels • Ointments • Suspensions • Emulsions • Liposomes & Nanoparticles By Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Glaucoma • Diabetic Retinopathy • Cataract • Dry Eye Syndrome • Macular Degeneration • Diabetic Macular Edema • Refractive Issues • Other Diseases By Setting, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Homecare Settings • Ambulatory Surgical Centers (ASCs) • Other Settings Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (Israel, UAE，Saudi Arabia, South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Dosage Form and Setting over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Aero Pump GmbH Allergan plc. AptarGroup, Inc. Becton, Dickinson and Company Biocorp Clearside Biomedical, Inc. EyePoint Pharmaceuticals, Inc. Gaplast GmbH Gerresheimer AG Jotteq Inc. Kedalion Therapeutics, Inc. Mati Therapeutics, Inc. Nemera Nipro Corporation Ocular Therapeutix, Inc. Ocumedic, Inc. Owen Mumford Re-Vana Therapeutics Silgan Holdings Inc. Terumo Corporation Valeant Pharmaceuticals International Inc. (Bausch Health Company) West Pharmaceutical Services, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Asia Pacific lipid nutrition market will grow by 8.9% annually with a total addressable market cap of $42,032.4 million over 2022-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surged need for plant-based nutrition source to offer vegans and vegetarians with required nutrition. Highlighted with 45 tables and 49 figures, this 112-page report “Asia Pacific Lipid Nutrition (Nutritional Lipids) Market 2021-2031 by Product (Omega-3, Omega-6, MCT, Phytosterols), Source (Plant, Animal), Form (Liquid, Powder), Application (Supplements & Nutraceuticals, Infant Formula, Pharmaceuticals, Food Fortification, Cosmetics and Personal Care, Others), Distribution (Direct Sales, Distributors), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific lipid nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific lipid nutrition market in every aspect of the classification from perspectives of by Product, Source, Form, Application, Distribution, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Omega-3 o Omega-3 revenue by Type (Eicosapentaenoic Acid, Docosahexaenoic Acid, α-Linolenic Acid) o Omega-3 revenue by Source (Microlagae Oil, Plant/Seed/Nut Oil, Krill Oil, Fish Oil) o Omega-3 revenue by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Food and Beverage, Other Applications) • Omega-6 o Omega-6 revenue by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Other Applications) • Medium Chain Triglycerides (MCT) o MCT Revenue by Product Form (Liquid, Powder) o MCT revenue by Application (Food and Nutrition, Cosmetics and Personal Care, Pharmaceuticals, Other Applications) • Phytosterols o Phytosterol revenue by Application (Food and Nutrition, Pharmaceuticals, Cosmetics and Personal Care, Other Applications) Based on Product, the Asia Pacific market is segmented into the following sub-markets with volume (thousand tons) for 2021-2031 included in each section. • Omega-3 o Omega-3 volume by Type (Eicosapentaenoic Acid, Docosahexaenoic Acid, α-Linolenic Acid) o Omega-3 volume by Source (Microlagae Oil, Plant/Seed/Nut Oil, Krill Oil, Fish Oil) o Omega-3 volume by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Food and Beverage, Other Applications) • Omega-6 o Omega-6 volume by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Other Applications) • Medium Chain Triglycerides (MCT) o MCT Volume by Product Form (Liquid, Powder) o MCT volume by Application (Food and Nutrition, Cosmetics and Personal Care, Pharmaceuticals, Other Applications) • Phytosterols o Phytosterol volume by Application (Food and Nutrition, Pharmaceuticals, Cosmetics and Personal Care, Other Applications) Based on Source, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Plant-based Products • Animal-based Products By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Dietary Supplements & Nutraceuticals • Infant Formula • Pharmaceuticals • Food Fortification • Cosmetics and Personal Care • Other Applications By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Direct Sales • Distributors Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Source and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Aker BioMarine BASF SE Croda International PLC DSM FMC Corporation IOI Oleo GmbH Kerry Group PLC Neptune Wellness Solutions Nordic Naturals, Inc. Pelagia AS Pharma Marine AS POLARIS Nutritional Lipids Stepan Company Sternchemie GmbH & Co. KG (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

Europe lipid nutrition market was valued at $2,073.7 million in 2021 and will grow by 6.1% annually over 2021-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surged need for plant-based nutrition source to offer vegans and vegetarians with required nutrition. Highlighted with 48 tables and 50 figures, this 114-page report “Europe Lipid Nutrition (Nutritional Lipids) Market 2021-2031 by Product (Omega-3, Omega-6, MCT, Phytosterols), Source (Plant, Animal), Form (Liquid, Powder), Application (Supplements & Nutraceuticals, Infant Formula, Pharmaceuticals, Food Fortification, Cosmetics and Personal Care, Others), Distribution (Direct Sales, Distributors), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe lipid nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe lipid nutrition market in every aspect of the classification from perspectives of by Product, Source, Form, Application, Distribution, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Omega-3 o Omega-3 revenue by Type (Eicosapentaenoic Acid, Docosahexaenoic Acid, α-Linolenic Acid) o Omega-3 revenue by Source (Microlagae Oil, Plant/Seed/Nut Oil, Krill Oil, Fish Oil) o Omega-3 revenue by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Food and Beverage, Other Applications) • Omega-6 o Omega-6 revenue by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Other Applications) • Medium Chain Triglycerides (MCT) o MCT Revenue by Product Form (Liquid, Powder) o MCT revenue by Application (Food and Nutrition, Cosmetics and Personal Care, Pharmaceuticals, Other Applications) • Phytosterols o Phytosterol revenue by Application (Food and Nutrition, Pharmaceuticals, Cosmetics and Personal Care, Other Applications) Based on Product, the Europe market is segmented into the following sub-markets with volume (thousand tons) for 2021-2031 included in each section. • Omega-3 o Omega-3 volume by Type (Eicosapentaenoic Acid, Docosahexaenoic Acid, α-Linolenic Acid) o Omega-3 volume by Source (Microlagae Oil, Plant/Seed/Nut Oil, Krill Oil, Fish Oil) o Omega-3 volume by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Food and Beverage, Other Applications) • Omega-6 o Omega-6 volume by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Other Applications) • Medium Chain Triglycerides (MCT) o MCT Volume by Product Form (Liquid, Powder) o MCT volume by Application (Food and Nutrition, Cosmetics and Personal Care, Pharmaceuticals, Other Applications) • Phytosterols o Phytosterol volume by Application (Food and Nutrition, Pharmaceuticals, Cosmetics and Personal Care, Other Applications) Based on Source, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Plant-based Products • Animal-based Products By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Dietary Supplements & Nutraceuticals • Infant Formula • Pharmaceuticals • Food Fortification • Cosmetics and Personal Care • Other Applications By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Direct Sales • Distributors Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Source and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Aker BioMarine BASF SE Croda International PLC DSM FMC Corporation IOI Oleo GmbH Kerry Group PLC Neptune Wellness Solutions Nordic Naturals, Inc. Pelagia AS Pharma Marine AS POLARIS Nutritional Lipids Stepan Company Sternchemie GmbH & Co. KG (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

44742

Global lipid nutrition market will reach $ 17,516.6 million by 2031, growing by 7.6% annually over 2021-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surged need for plant-based nutrition source to offer vegans and vegetarians with required nutrition. Highlighted with 100 tables and 84 figures, this 171-page report “Global Lipid Nutrition (Nutritional Lipids) Market 2021-2031 by Product (Omega-3, Omega-6, MCT, Phytosterols), Source (Plant, Animal), Form (Liquid, Powder), Application (Supplements & Nutraceuticals, Infant Formula, Pharmaceuticals, Food Fortification, Cosmetics and Personal Care, Others), Distribution (Direct Sales, Distributors), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global lipid nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global lipid nutrition market in every aspect of the classification from perspectives of by Product, Source, Form, Application, Distribution, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Omega-3 o Omega-3 revenue by Type (Eicosapentaenoic Acid, Docosahexaenoic Acid, α-Linolenic Acid) o Omega-3 revenue by Source (Microlagae Oil, Plant/Seed/Nut Oil, Krill Oil, Fish Oil) o Omega-3 revenue by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Food and Beverage, Other Applications) • Omega-6 o Omega-6 revenue by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Other Applications) • Medium Chain Triglycerides (MCT) o MCT Revenue by Product Form (Liquid, Powder) o MCT revenue by Application (Food and Nutrition, Cosmetics and Personal Care, Pharmaceuticals, Other Applications) • Phytosterols o Phytosterol revenue by Application (Food and Nutrition, Pharmaceuticals, Cosmetics and Personal Care, Other Applications) Based on Product, the global market is segmented into the following sub-markets with volume (thousand tons) for 2021-2031 included in each section. • Omega-3 o Omega-3 volume by Type (Eicosapentaenoic Acid, Docosahexaenoic Acid, α-Linolenic Acid) o Omega-3 volume by Source (Microlagae Oil, Plant/Seed/Nut Oil, Krill Oil, Fish Oil) o Omega-3 volume by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Food and Beverage, Other Applications) • Omega-6 o Omega-6 volume by Application (Dietary Supplements, Infant Nutrition, Pharmaceuticals, Other Applications) • Medium Chain Triglycerides (MCT) o MCT Volume by Product Form (Liquid, Powder) o MCT volume by Application (Food and Nutrition, Cosmetics and Personal Care, Pharmaceuticals, Other Applications) • Phytosterols o Phytosterol volume by Application (Food and Nutrition, Pharmaceuticals, Cosmetics and Personal Care, Other Applications) Based on Source, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Plant-based Products • Animal-based Products By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Dietary Supplements & Nutraceuticals • Infant Formula • Pharmaceuticals • Food Fortification • Cosmetics and Personal Care • Other Applications By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Direct Sales • Distributors Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE，Saudi Arabia， South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Source and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Aker BioMarine BASF SE Croda International PLC DSM FMC Corporation IOI Oleo GmbH Kerry Group PLC Neptune Wellness Solutions Nordic Naturals, Inc. Pelagia AS Pharma Marine AS POLARIS Nutritional Lipids Stepan Company Sternchemie GmbH & Co. KG (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) ...

44742

LATEST REPORTS

PRESS RELEASES

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT